General Diagnostics International Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 4.86 Cr
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.39 Cr
- Satisfied Charges ₹ 16.04 Cr
- Revenue Growth -33.38%
- Profit Growth -215.22%
- Ebitda -119.52%
- Net Worth -52.27%
- Total Assets -27.92%
About General Diagnostics International
General Diagnostics International Private Limited (GDIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 April 2007 and has a history of 17 years and ten months. Its registered office is in Navi Mumbai, Maharashtra, India.
The Corporate was formerly known as Preventine Life Care Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.86 Cr.
The company currently has active open charges totaling ₹2.39 Cr. The company has closed loans amounting to ₹16.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at General Diagnostics International Private Limited India is Abhimanyu Kumar as CEO. Jeevak Gupta, Susheel Singh, and Abhimanyu Kumar serve as directors at the Company.
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
- Apps
Corporate Identity Details
- CIN/LLPIN
U85100MH2007PTC169607
- Company No.
169607
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 2007
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does General Diagnostics International Private Limited offer?
General Diagnostics International Private Limited offers a wide range of products and services, including SEO Consultation Service, SEO Solution, Designing Services, Concept Designing Service, Medical Treatment Services, Sleep Disorder Treatment, Health Care Service, Diagnostic Imaging & Pathology Labs, Medical Test Services, Pediatric Care Facilities.
Who are the key members and board of directors at General Diagnostics International?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Abhimanyu Kumar | CEO | 25-May-2023 | Current |
Susheel Singh ![]() | Managing Director | 03-Apr-2007 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jeevak Gupta | Nominee Director | 25-May-2023 | Current |
Financial Performance of General Diagnostics International.
General Diagnostics International Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.38% decrease. The company also saw a substantial fall in profitability, with a 215.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 52.27%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of General Diagnostics International?
In 2023, General Diagnostics International had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹2.39 Cr
₹16.04 Cr
Charges Breakdown by Lending Institutions
- Others : 1.33 Cr
- Yes Bank Limited : 0.73 Cr
- Axis Bank Limited : 0.33 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
01 Feb 2021 | Axis Bank Limited | ₹3.32 M | Open |
14 Aug 2020 | Others | ₹1.65 M | Open |
30 Jul 2020 | Yes Bank Limited | ₹0.78 M | Open |
27 Jul 2020 | Others | ₹2.70 M | Open |
26 Nov 2019 | Others | ₹1.67 M | Open |
How Many Employees Work at General Diagnostics International?
General Diagnostics International has a workforce of 365 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of General Diagnostics International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped General Diagnostics International's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.